AVAI BIO, INC. Deferred Tax Assets, Operating Loss Carryforwards
AVAI BIO, INC. (AVAI) had Deferred Tax Assets, Operating Loss Carryforwards of $5.87 million as of 2026-03-31, per its 10-K filed 2026-07-14.
Financial Statements › Notes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-07-14
- 2026-03-31: Deferred Tax Assets, Operating Loss Carryforwards $5.87M.
- 2025-03-31: Deferred Tax Assets, Operating Loss Carryforwards $4.12M.
- 2024-03-31: Deferred Tax Assets, Operating Loss Carryforwards $2.98M.
- 2023-03-31: Deferred Tax Assets, Operating Loss Carryforwards $847.92K.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2026-03-31 | $5.87M 10-K · filed 2026-07-14 | |
| 2025-03-31 | $4.12M 10-K · filed 2026-07-14 | |
| 2024-03-31 | $2.98M 10-K · filed 2025-07-08 | |
| 2023-03-31 | $847.92K 10-K/A · filed 2025-02-19 | |
| 2022-03-31 | $495.85K 10-K/A · filed 2023-07-13 | |
| 2021-03-31 | $315.06K 10-K · filed 2022-06-29 | $66.16K 10-K · filed 2021-07-13 |
| 2020-03-31 | $14.08K 10-K/A · filed 2021-08-18 |